Illegal Ecstasy Takes Step Toward Becoming Legal Drug for PTSD
Bloomberg Businessweek
00:00
MDMA Therapy for Treating PTSD: Controversies and Challenges
The chapter explores the development of a new form of MDMA for treating PTSD, examining the company involved, controversies, and challenges in clinical trials. It discusses the urgent need for solutions amidst the large number of PTSD sufferers, the therapy involved, and the FDA's review of this innovative treatment. The conversation also delves into the debate on the drug's effectiveness without the ecstatic experience, current limitations in PTSD treatments, and the investment landscape in biotech companies.
Play episode from 01:54
Transcript
